{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:43:48Z","timestamp":1753883028257,"version":"3.41.2"},"reference-count":23,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/AuthorWarrantyLicense.v1"},{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"HHS | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["HHSN261201500003I","75N91019D00024"],"award-info":[{"award-number":["HHSN261201500003I","75N91019D00024"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"HHS | NIH | NIH Office of the Director","doi-asserted-by":"publisher","award":["OT2OD026552"],"award-info":[{"award-number":["OT2OD026552"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"HHS | NIH | NIH Office of the Director","doi-asserted-by":"publisher","award":["1OT2OD026553","3OT2OD026553-01S3"],"award-info":[{"award-number":["1OT2OD026553","3OT2OD026553-01S3"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000098","name":"HHS | NIH | NIH Clinical Center","doi-asserted-by":"publisher","award":["U2OD023196"],"award-info":[{"award-number":["U2OD023196"]}],"id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000098","name":"HHS | NIH | NIH Clinical Center","doi-asserted-by":"publisher","award":["5 U2C OD023196-03"],"award-info":[{"award-number":["5 U2C OD023196-03"]}],"id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000098","name":"HHS | NIH | NIH Clinical Center","doi-asserted-by":"publisher","award":["5U2COD023196-04"],"award-info":[{"award-number":["5U2COD023196-04"]}],"id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["mSphere"],"published-print":{"date-parts":[[2022,10,26]]},"abstract":"<jats:p>What is the agreement of commercial SARS-CoV-2 immunoglobulin G (IgG) assays during a time of low coronavirus disease 2019 (COVID-19) prevalence and no vaccine availability? Serological tests produced concordant results in a time of low SARS-CoV-2 prevalence and no vaccine availability, driven largely by the proportion of samples that were negative by two immunoassays. The CDC recommends two sequential tests for positivity for future pandemic preparedness.<\/jats:p>","DOI":"10.1128\/msphere.00257-22","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T12:02:04Z","timestamp":1664452924000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":1,"title":["Concordance of SARS-CoV-2 Antibody Results during a Period of Low Prevalence"],"prefix":"10.1128","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3665-704X","authenticated-orcid":true,"given":"Cheryl N.","family":"Miller","sequence":"first","affiliation":[{"name":"Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keri N.","family":"Althoff","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Schlueter","sequence":"additional","affiliation":[{"name":"National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA"},{"name":"Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoda","family":"Anton-Culver","sequence":"additional","affiliation":[{"name":"Department of Medicine, School of Medicine, University of California, Irvine, Irvine, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingxia","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn","family":"Garbett","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"Ratsimbazafy","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac","family":"Thomsen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth W.","family":"Karlson","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Brigham and Women\u2019s Hospital, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mine","family":"Cicek","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3130-9882","authenticated-orcid":true,"given":"Ligia A.","family":"Pinto","sequence":"additional","affiliation":[{"name":"Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley A.","family":"Malin","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucila","family":"Ohno-Machado","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, University of California\u2014San Diego Health, La Jolla, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Williams","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Goldstein","sequence":"additional","affiliation":[{"name":"Columbia University Medical Center, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aymone","family":"Kouame","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Ramirez","sequence":"additional","affiliation":[{"name":"All of Us Research Program, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly A.","family":"Gebo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheri D.","family":"Schully","sequence":"additional","affiliation":[{"name":"All of Us Research Program, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","volume-title":"EUA authorized serology test performance.","author":"US Food and Drug Administration","year":"2020","unstructured":"US Food and Drug Administration. 2020. EUA authorized serology test performance. US Food and Drug Administration, Silver Spring, MD. https:\/\/www.fda.gov\/medical-devices\/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices\/eua-authorized-serology-test-performance."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01564-21"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa310"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa344"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2021.02.001"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02257-20"},{"key":"e_1_3_2_8_2","volume-title":"Interim guidelines for COVID-19 antibody testing: interim guidelines for COVID-19 antibody testing in clinical and public health settings.","author":"Centers for Disease Control and Prevention","year":"2021","unstructured":"Centers for Disease Control and Prevention. 2021. Interim guidelines for COVID-19 antibody testing: interim guidelines for COVID-19 antibody testing in clinical and public health settings. Centers for Disease Control and Prevention, Atlanta, GA. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/lab\/resources\/antibody-tests-guidelines.html."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab519"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00514-21"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2025179"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03207-w"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abe0367"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa273"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyaa134"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1785"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.4130"},{"key":"e_1_3_2_18_2","volume-title":"UK Biobank SARS-CoV-2 serology study (weekly report\u201421 July 2020).","author":"UK Biobank","year":"2020","unstructured":"UK Biobank. 2020. UK Biobank SARS-CoV-2 serology study (weekly report\u201421 July 2020). UK Biobank, Stockport, United Kingdom. https:\/\/www.ukbiobank.ac.uk\/media\/s3af0k5q\/ukb_serologystudy_month1_report.pdf."},{"key":"e_1_3_2_19_2","volume-title":"Antibody (serology) testing for COVID-19: information for patients and consumers.","author":"US Food and Drug Administration","year":"2022","unstructured":"US Food and Drug Administration. 2022. Antibody (serology) testing for COVID-19: information for patients and consumers. US Food and Drug Administration, Silver Spring, MD. https:\/\/www.fda.gov\/medical-devices\/coronavirus-covid-19-and-medical-devices\/antibody-serology-testing-covid-19-information-patients-and-consumers#mean."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsr1809937"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102052"},{"key":"e_1_3_2_22_2","volume-title":"Data and statistics dissemination policy: update on 5\/12\/2020.","author":"All of Us Research Program","year":"2020","unstructured":"All of Us Research Program. 2020. Data and statistics dissemination policy: update on 5\/12\/2020. All of Us Research Program, National Institutes of Health, Bethesda, MD. https:\/\/www.researchallofus.org\/wp-content\/themes\/research-hub-wordpress-theme\/media\/2020\/05\/AoU_Policy_Data_and_Statistics_Dissemination_508.pdf."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","unstructured":"Freeman B Lester S Mills L Rasheed MAU Moye S Abiona O Hutchinson GB Morales-Betoulle M Krapinunaya I Gibbons A Chiang C-F Cannon D Klena J Johnson JA Owen SM Graham BS Corbett KS Thornburg NJ. 2020. Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and serosurveillance. bioRxiv. doi:10.1101\/2020.04.24.057323.","DOI":"10.1101\/2020.04.24.057323"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/9780470580066"}],"container-title":["mSphere"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/msphere.00257-22","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/msphere.00257-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T13:05:52Z","timestamp":1666789552000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/msphere.00257-22"}},"subtitle":[],"editor":[{"given":"Marcela F.","family":"Pasetti","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,10,26]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10,26]]}},"alternative-id":["10.1128\/msphere.00257-22"],"URL":"https:\/\/doi.org\/10.1128\/msphere.00257-22","relation":{},"ISSN":["2379-5042"],"issn-type":[{"type":"electronic","value":"2379-5042"}],"subject":[],"published":{"date-parts":[[2022,10,26]]},"assertion":[{"value":"2022-06-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00257-22"}}